Tomasz Milewicz

Tomasz Milewicz

Auto-generated profile, based on publicly available information

Tomasz Milewicz

Department of Gynecological Endocrinology, Jagiellonian University Medical College, 31-501 Krakow, Poland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
MDMonika Dawid
Monika Dawid
EMEwa Mlyczyńska
Ewa Mlyczyńska
MJMałgorzata Jurek
Małgorzata Jurek
NRNatalia Respekta
Natalia Respekta
KPKarolina Pich
Karolina Pich
Agnieszka RakAgnieszka Rak
Agnieszka Rak
The apelinergic system, which includes the apelin receptor (APJ) as well as its two specific ligands, namely apelin and ELABELA (ELA/APELA/Toddler), have been the subject of many recent studies due to their pleiotropic effects in humans and other animals. Expression of these factors has been investigated in numerous tissues and organs—for example, the lungs, heart, uterus, and ovary. Moreover, a number of studies have been devoted to understanding the role of apelin and the entire apelinergic system in the most important processes in the body, starting from early stages of human life with regulation of placental function and the proper course of pregnancy. Disturbances in the balance of placental processes such as proliferation, apoptosis, angiogenesis, or hormone secretion may lead to specific pregnancy pathologies; therefore, there is a great need to search for substances that would help in their early diagnosis or treatment. A number of studies have indicated that compounds of the apelinergic system could serve this purpose. Hence, in this review, we summarized the most important reports about the role of apelin and the entire apelinergic system in the regulation of placental physiology and pregnancy.

Verified
Journal Article
Open access
PDF file
EMEwa Mlyczyńska
Ewa Mlyczyńska
MMMałgorzata Myszka
Małgorzata Myszka
PKPatrycja Kurowska
Patrycja Kurowska
MDMonika Dawid
Monika Dawid
TMTomasz Milewicz
Tomasz Milewicz
Agnieszka RakAgnieszka Rak
Agnieszka Rak
Previously, we demonstrated the expression of apelin and G-protein-coupled receptor APJ in human placenta cell lines as well as its direct action on placenta cell proliferation and endocrinology. The objective of this study was to examine the effect of apelin on placenta apoptosis in BeWo cells and villous explants from the human third trimester of pregnancy. The BeWo cells and villous explants were incubated with apelin (2 and 20 ng/mL) alone or with staurosporine for 24 to 72 h. First, we analysed the dose- and time-dependent effect of apelin on the expression of apoptotic factors on the mRNA level by real-time PCR and on the protein level using Western blot. Next, we checked caspase 3 and 7 activity by Caspase-Glo 3/7, DNA fragmentation by the Cell Death Detection ELISA kit and oxygen consumption by the MitoXpress-Xtra Oxygen Consumption assay. We found that apelin increased the expression of pro-survival and decreased proapoptotic factors on mRNA and protein levels in both BeWo cells and villous explants. Additionally, apelin inhibited caspase 3 and 7 activity and DNA fragmentation in staurosporine-induced apoptosis as also attenuated oxidative stress by increasing extracellular oxygen consumption. The antiapoptotic effect of apelin in BeWo cells was mediated by the APJ receptor and mitogen-activated protein kinase (ERK1/2/MAP3/1) and protein kinase B (AKT). The obtained results showed the antiapoptotic effect of apelin on trophoblast cells, suggesting its participation in the development of the placenta.

21 January 2016 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
MKM. Kiałka
M. Kiałka
TMT. Milewicz
T. Milewicz
MSMagdalena Spałkowska
Magdalena Spałkowska
MKM. Krzyczkowska-Sendrakowska
M. Krzyczkowska-Sendrakowska
BWB. Wasyl
B. Wasyl
JKJ. Krzysiek
J. Krzysiek
Aim: The evaluation the β-endorphin plasma levels in lean women with polycystic ovary syndrome as well as in women without this disorder. The associations between β-endorphins and other laboratory parameters were also investigated. Materials and methods: 31 women lean, defined as women with normal range body mass index, 15 with polycystic ovary syndrome and 16 without this disorder were included to the study. In all the patients the level of β-endorphins was measured. Also the diagnostic laboratory profile including hormone assessment was made in all patients. Results: There were significant differences in β-endorphin levels between the 2 groups. The β-endorphin level was higher in the polycystic ovary syndrome group compared to the healthy controls (15.5±4.37 pg/ml vs. 6.9±2.47 pg/ml, p<0.0001). The β-endorphin levels positively correlated with cortisol at 8 am (R=0.632, p=0.011) and negatively correlated with sex hormone binding globuline (R=0.518, p=0.0478) in polycystic ovary syndrome group. Increase in β-endorphin level of 1 pg/ml was associated with an increase of cortisol at 8 am level of 1.134 µg/dl and decrease of sex hormone binding globuline of 0.948 nmol/l in polycystic ovary syndrome group. Conclusion: Our study showed that the levels of β-endorphins were significantly higher in lean patients with polycystic ovary syndrome than in lean controls. Moreover, β-endorphins levels were found to be correlated with other hormonal parameters. In this respect, β-endorphins may play a role in polycystic ovary syndrome pathophysiology.

14 October 2023 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
KGKatarzyna Gawlik
Katarzyna Gawlik
TMTomasz Milewicz
Tomasz Milewicz
DPDorota Pawlica-Gosiewska
Dorota Pawlica-Gosiewska
ITIwona Trznadel-Morawska
Iwona Trznadel-Morawska
BSBogdan Solnica
Bogdan Solnica
Objective. Women who develop GDM present a metabolic condition similar to that found in type 2 diabetes, characterized by impaired insulin response. Due to similar pathophysiologic mechanisms found between type 2DM and GDM, there is a great interest in finding markers that will lead to the understanding of a possible common origin to both diseases. The aim of this study was to determine serum FGF21 levels in 2DM and GDM and its correlation with selected metabolic parameters. Method. The study included 54 2DM patients and 52 nondiabetic individuals (control group 1) as well as 74 GDM women and 32 healthy pregnant controls (control group 2). Serum FGF21 was determined by enzyme-linked immunosorbent assay (ELISA), in all groups, and correlated with biochemical parameters of glucose metabolism and insulin resistance (HbA1c, HOMA index, TG, and HDL cholesterol). Results. FGF21 concentration was significantly higher in 2DM as compared with control group 1 ( ). In the 2DM group, FGF21 was positively correlated with HOMA index ( , ). In the GDM group, the positive relationships with FGF21 were observed with glucose ( , ) and TG ( , ) while HDL-C levels were correlated negatively ( , ). Conclusion. Serum FGF21 levels were significantly higher in 2DM patients than those without diabetes. Moreover, serum FGF21 levels were associated with selected metabolic parameters, suggesting that it may play acrolein glucose and lipid metabolism.

1 January 2008 in Gynecological Endocrinology
Verified
Journal Article
Closed access
AWAnna Katarzyna Wójtowicz
Anna Katarzyna Wójtowicz
TMTomasz Milewicz
Tomasz Milewicz
EGEwa Ł. Gregoraszczuk
Ewa Ł. Gregoraszczuk
Explants of human placenta were used to study the effects of two isomers of DDT (1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane) [p,p′-DDT and o,p′-DDT] and their DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene) metabolites [p,p′-DDE and o,p′-DDE] on the secretion of progesterone and human chorionic gonadotropin (hCG). Explants were treated with 1, 10, 100 or 1000 ng/ml of each compound for 24 h or 72 h. We found opposite effects (stimulatory after short-term and inhibitory after long-term exposure) of all compounds on progesterone secretion. However, both short- and long-term exposure to all investigated compounds caused decreased hCG secretion. In conclusion, we suggest the existence of a local axis between steroid hormones and hCG in placenta. DDT (which has estrogenic properties) increases progesterone secretion and consequently decreases hCG secretion. After long-term exposure, the low level of hCG is insufficient to stimulate progesterone.

10 February 2020 in Gynecological Endocrinology
Verified
Journal Article
Closed access
MKMonika Kujdowicz
Monika Kujdowicz
TMTomasz Milewicz
Tomasz Milewicz
DADariusz Adamek
Dariusz Adamek
The article presents a case of a 28-year-old woman with so-called morulosis – a form of squamous metaplasia of the endometrium, which may mimic malignancy. The term ‘morulosis’ indicates extensive squamous mulberry-like metaplasia, which in a large part or nearly entirely affects endometrium, whereas in turn, benign squamous metaplasia or single morules, refers to a limited, usually small regional pathology of endometrium. Because the endometrial glands and stroma gradually undergo the process of squamous metaplasia, in a scanty biopsy material the picture may lead to overdiagnosis. In the epithelioid regions small inactive glands with an immunofenotype different from the remaining endometrium might be observed. So far 21 cases have been reported in English literature. The patients (age 19–45) had presented with abnormal bleeding, infertility or after hormonal therapy. The mechanism of the extensive squamous metaplasia of endometrium is still not clear. The prevailing view holds that morulosis appears to be a result of hormonal imbalance. To shed light on possible pathogenic background of morulosis, we present a case of particularly severe extensive squamous metaplasia of the endometrium (morulosis).